DAWN
NASDAQ
$21.53
Day One Biopharmaceuticals Inc (DAWN)
Sector:
Healthcare
Industry:
Biotechnology
Market Cap
$2.22B
Free Cash Flow Yield
-4.69%
Price Chart
Valuation
Market Cap$2.22B
Profitability
Total Revenue (TTM)$158M
Gross Profit (TTM)$141M
EBITDA-$127M
Profit Margin-39.6%
Operating Margin-51.1%
EPS-$1.05
Financial Health
Free Cash Flow Yield-4.69%
Growth & Risk
Sharpe Ratio1.46